#ThinkSabio Latest News
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)
Autolus Therapeutics plc (AUTL) Stock Price, Latest News, Company Profile & Institutional Holding
